v3.26.1
EQUITY COMPENSATION PLANS (Tables)
6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of RSAs transaction activity
          
   Restricted
Common Stock
Award Shares
  Weighted Average
Grant Date Fair
Value ($)
Unvested balance at December 31, 2025   17,617    3.10 
Granted   –    – 
Vested   (5,049)   2.11 
Forfeited   –    – 
Unvested balance at June 30, 2026   12,568    3.50 
Schedule of RSUs transaction activity
          
   Restricted
Common Stock
Unit Shares
  Weighted Average
Grant Date Fair
Value ($)
Outstanding at December 31, 2025   617,236    9.13 
Granted   –    – 
Vested and settled   (342,055)   9.14 
Forfeited   –    – 
Outstanding at June 30, 2026   275,181    9.13 
Unvested at June 30, 2026   275,181    9.13 
Schedule of stock option transaction activity
          
   Number of
Stock Options
  Grant Date
Weighted
Average
Exercise Price
($)
Outstanding at December 31, 2025   1,841,977    6.51 
Options granted   950,000    2.48 
Options exercised   –    – 
Options canceled and forfeited   (36,141)   4.85 
Outstanding at June 30, 2026   2,755,836    5.14 
Schedule of assumptions
     
Expected volatility   99.95% 
Risk-free interest rate   4.03% 
Expected dividend yield   0.00% 
Expected term (in years)   6.01 
Schedule of stock-based compensation expense
                    
   Three Months Ended June 30,  Six Months Ended June 30,
   2026  2025  2026  2025
Research and development  $195,048   $88,363   $351,718   $217,289 
General and administrative   1,145,721    1,490,908    2,345,440    2,487,083 
Total  $1,340,769   $1,579,271   $2,697,158   $2,704,372